Treatment of Incontinence without Memory Problems (TRIuMPh)

-
Sponsor: Astellas Pharma, Inc.

Location(s): United States

Description

An 8-week randomized, controlled, pilot clinical trial of Mirabegron compared to a standard anticholinergic therapy (Detrol LA) in elderly women with urgency urinary incontinence.